The Journal of Urology
Volume 177, Issue 4 , Pages 1313-1317 , April 2007

Detection of Sentinel Node Micrometastasis by Step Section and Immunohistochemistry in Patients With Prostate Cancer

  • Mamoru Fukuda

      Affiliations

    • Department of Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Masayuki Egawa

      Affiliations

    • Department of Urology, Tonami General Hospital, Tonami, Japan
    • Corresponding Author InformationCorrespondence and requests for reprints: Department of Urology, Tonami General Hospital, 1-61 Shintomi-cho, Tonami 939-1395, Japan (telephone: +81-763-32-3320; FAX: +81-763-33-1487).
    • ,
  • Tetsuya Imao

      Affiliations

    • Department of Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Hiroshi Takashima

      Affiliations

    • Department of Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Kunihiko Yokoyama

      Affiliations

    • Department of Biotracer Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan
    • ,
  • Mikio Namiki

      Affiliations

    • Department of Urology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan

Received 13 July 2006

References 

  1. Bhatta-Dhar N, Reuther AM, Zippe C, Klein EA. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer. Urology. 2004;63:528
  2. Wawroschek F, Vogt H, Wengenmair H, Weckermann D, Hamm M, Keil M, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer (Technique and results of the first 350 cases). Urol Int. 2003;70:303
  3. Bader P, Burkhard FC, Markwalder R, Studer UE. Is a limited lymph node dissection an adequate staging procedure for prostate cancer?. J Urol. 2002;168:514
  4. Heidenreich A, Varga Z, VonKnobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol. 2002;167:1681
  5. Takashima H, Egawa M, Imao T, Fukuda M, Yokoyama K, Namiki M. Validity of sentinel lymph node concept for patients with prostate cancer. J Urol. 2004;171:2268
  6. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer. 1977;39:456
  7. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392
  8. Bilchik AJ, Giuliano A, Essner R, Bostick P, Kelemen P, Foshag LJ, et al. Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms. Cancer J Sci Am. 1998;4:351
  9. Morton DL, Cochran AJ, Thompson JF, Elashoff R, Essner R, Glass EC, et al. Multicenter Selective Lymphadenectomy Trial Group Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I, an international multicenter trial. Ann Surg. 2005;242:302
  10. Posther KE, Wilke LG, Giuliano AE. Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping. Semin Oncol. 2004;31:426
  11. Kitagawa Y, Fujii H, Kumai K, Kubota T, Otani Y, Saikawa Y, et al. Recent advances in sentinel node navigation for gastric cancer: a paradigm shift of surgical management. J Surg Oncol. 2005;90:147
  12. Wawroschek F, Vogt H, Weckermann D, Wagner T, Harzmann R. The sentinel lymph node concept in prostate cancer – first results of gamma probe-guided sentinel lymph node identification. Eur Urol. 1999;36:595
  13. Wawroschek F, Wagner T, Hamm M, Weckermann D, Vogt H, Markl B, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol. 2003;43:132
  14. Kizu H, Takayama T, Fukuda M, Egawa M, Tsushima H, Yamada M, et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol. 2005;33:78
  15. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer (A multi-institutional update). JAMA. 1997;277:1445
  16. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341:1781
  17. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol. 2004;172:1840
  18. Daneshmand S, Quek ML, Stein JP, Lieskovsky G, Cai J, Pinski J, et al. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol. 2004;172:2252
  19. Bader P, Burkhard FC, Markwalder R, Studer UE. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy (Is there a chance of cure?). J Urol. 2003;169:849
  20. Klotz LH, Goldenberg SL, Jewett MA, Fradet Y, Nam R, Barkin J, et al. Canadian Uro-Oncology Group Long-term followup of a randomized trial of 0 versus 3 months of neoadjuvant androgen ablation before radical prostatectomy. J Urol. 2003;170:791

 Study received institutional ethics committee approval (approval reference 201).

PII: S0022-5347(06)03094-1

doi: 10.1016/j.juro.2006.11.085

The Journal of Urology
Volume 177, Issue 4 , Pages 1313-1317 , April 2007

Article Tools

* Image Usage & Resolution